Western blotting was carried out for exploring the downstream genes of ERBB2/ERBB3 in GC cells after treated with miR-200b mimic, miR-200b inhibitor, or combined with NRG1 siRNA. This evidence concerns the gene ERBB3 and gastric cancer.